TREACE MEDICAL CONCEPTS INC (TMCI) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:TMCI • US89455T1097

2.135 USD
-0.12 (-5.53%)
Last: Feb 9, 2026, 11:43 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, TMCI scores 3 out of 10 in our fundamental rating. TMCI was compared to 186 industry peers in the Health Care Equipment & Supplies industry. TMCI has a bad profitability rating. Also its financial health evaluation is rather negative. TMCI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year TMCI has reported negative net income.
  • In the past year TMCI has reported a negative cash flow from operations.
  • TMCI had negative earnings in each of the past 5 years.
  • TMCI had a negative operating cash flow in each of the past 5 years.
TMCI Yearly Net Income VS EBIT VS OCF VS FCFTMCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M -50M

1.2 Ratios

  • TMCI has a Return On Assets (-25.49%) which is in line with its industry peers.
  • TMCI's Return On Equity of -56.18% is in line compared to the rest of the industry. TMCI outperforms 48.92% of its industry peers.
Industry RankSector Rank
ROA -25.49%
ROE -56.18%
ROIC N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
TMCI Yearly ROA, ROE, ROICTMCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

  • The Gross Margin of TMCI (79.87%) is better than 93.01% of its industry peers.
  • TMCI's Gross Margin has been stable in the last couple of years.
  • TMCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 79.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
TMCI Yearly Profit, Operating, Gross MarginsTMCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • TMCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TMCI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for TMCI has been increased compared to 5 years ago.
  • TMCI has a worse debt/assets ratio than last year.
TMCI Yearly Shares OutstandingTMCI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
TMCI Yearly Total Debt VS Total AssetsTMCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • TMCI has an Altman-Z score of -0.01. This is a bad value and indicates that TMCI is not financially healthy and even has some risk of bankruptcy.
  • TMCI has a Altman-Z score (-0.01) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that TMCI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of TMCI (0.62) is worse than 63.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z -0.01
ROIC/WACCN/A
WACC10.32%
TMCI Yearly LT Debt VS Equity VS FCFTMCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • TMCI has a Current Ratio of 3.37. This indicates that TMCI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.37, TMCI is doing good in the industry, outperforming 61.29% of the companies in the same industry.
  • TMCI has a Quick Ratio of 2.36. This indicates that TMCI is financially healthy and has no problem in meeting its short term obligations.
  • TMCI's Quick ratio of 2.36 is in line compared to the rest of the industry. TMCI outperforms 59.68% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 2.36
TMCI Yearly Current Assets VS Current LiabilitesTMCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • TMCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.89%, which is quite good.
  • TMCI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.90%.
  • The Revenue has been growing by 39.66% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4%
Revenue 1Y (TTM)7.9%
Revenue growth 3Y30.41%
Revenue growth 5Y39.66%
Sales Q2Q%11.37%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.19% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 14.54% on average over the next years. This is quite good.
EPS Next Y4.7%
EPS Next 2Y-1.19%
EPS Next 3Y0.13%
EPS Next 5Y14.19%
Revenue Next Year2.04%
Revenue Next 2Y0.97%
Revenue Next 3Y3.56%
Revenue Next 5Y14.54%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
TMCI Yearly Revenue VS EstimatesTMCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
TMCI Yearly EPS VS EstimatesTMCI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • TMCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TMCI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TMCI Price Earnings VS Forward Price EarningsTMCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TMCI Per share dataTMCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.19%
EPS Next 3Y0.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TMCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TREACE MEDICAL CONCEPTS INC

NASDAQ:TMCI (2/9/2026, 11:43:04 AM)

2.135

-0.12 (-5.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners61.21%
Inst Owner Change-0.53%
Ins Owners20.74%
Ins Owner Change-0.95%
Market Cap136.04M
Revenue(TTM)218.88M
Net Income(TTM)-50.11M
Analysts50.91
Price Target4.93 (130.91%)
Short Float %6.33%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.88%
Min EPS beat(2)4.79%
Max EPS beat(2)8.96%
EPS beat(4)4
Avg EPS beat(4)26.76%
Min EPS beat(4)4.79%
Max EPS beat(4)74.58%
EPS beat(8)7
Avg EPS beat(8)13.87%
EPS beat(12)10
Avg EPS beat(12)14.08%
EPS beat(16)12
Avg EPS beat(16)-130.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)-1.01%
Revenue beat(4)1
Avg Revenue beat(4)-0.75%
Min Revenue beat(4)-1.26%
Max Revenue beat(4)0.3%
Revenue beat(8)5
Avg Revenue beat(8)0.36%
Revenue beat(12)8
Avg Revenue beat(12)1.09%
Revenue beat(16)12
Avg Revenue beat(16)2.15%
PT rev (1m)-9.37%
PT rev (3m)-43.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8882.04%
EPS NY rev (1m)0%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-20.87%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 1.97
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS3.44
BVpS1.4
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.49%
ROE -56.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 79.87%
FCFM N/A
ROA(3y)-24.09%
ROA(5y)-19.45%
ROE(3y)-52.01%
ROE(5y)-143.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.08%
F-Score3
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 141.2%
Cap/Sales 6.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 2.36
Altman-Z -0.01
F-Score3
WACC10.32%
ROIC/WACCN/A
Cap/Depr(3y)349.5%
Cap/Depr(5y)305.94%
Cap/Sales(3y)7.38%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4%
EPS Next Y4.7%
EPS Next 2Y-1.19%
EPS Next 3Y0.13%
EPS Next 5Y14.19%
Revenue 1Y (TTM)7.9%
Revenue growth 3Y30.41%
Revenue growth 5Y39.66%
Sales Q2Q%11.37%
Revenue Next Year2.04%
Revenue Next 2Y0.97%
Revenue Next 3Y3.56%
Revenue Next 5Y14.54%
EBIT growth 1Y22.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.29%
EBIT Next 3Y24.66%
EBIT Next 5Y26.75%
FCF growth 1Y49.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y69.98%
OCF growth 3YN/A
OCF growth 5YN/A

TREACE MEDICAL CONCEPTS INC / TMCI FAQ

Can you provide the ChartMill fundamental rating for TREACE MEDICAL CONCEPTS INC?

ChartMill assigns a fundamental rating of 3 / 10 to TMCI.


What is the valuation status of TREACE MEDICAL CONCEPTS INC (TMCI) stock?

ChartMill assigns a valuation rating of 0 / 10 to TREACE MEDICAL CONCEPTS INC (TMCI). This can be considered as Overvalued.


Can you provide the profitability details for TREACE MEDICAL CONCEPTS INC?

TREACE MEDICAL CONCEPTS INC (TMCI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for TREACE MEDICAL CONCEPTS INC?

The Earnings per Share (EPS) of TREACE MEDICAL CONCEPTS INC (TMCI) is expected to grow by 4.7% in the next year.